1. Home
  2. TMDX vs WGS Comparison

TMDX vs WGS Comparison

Compare TMDX & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$141.71

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$108.65

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
WGS
Founded
1998
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.6B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
TMDX
WGS
Price
$141.71
$108.65
Analyst Decision
Buy
Strong Buy
Analyst Count
8
8
Target Price
$144.25
$138.13
AVG Volume (30 Days)
660.2K
554.5K
Earning Date
02-26-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
170.70
N/A
EPS
2.54
0.07
Revenue
$566,354,000.00
$402,190,000.00
Revenue This Year
$38.81
$41.17
Revenue Next Year
$20.49
$23.53
P/E Ratio
$56.53
$1,499.76
Revenue Growth
41.20
50.50
52 Week Low
$55.00
$55.17
52 Week High
$156.00
$170.87

Technical Indicators

Market Signals
Indicator
TMDX
WGS
Relative Strength Index (RSI) 63.09 26.62
Support Level $134.00 $103.01
Resistance Level $151.85 $113.24
Average True Range (ATR) 6.57 8.17
MACD 1.73 -2.74
Stochastic Oscillator 68.91 13.21

Price Performance

Historical Comparison
TMDX
WGS

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: